RYTM
Rhythm Pharmaceuticals Inc.

2,030
Mkt Cap
$5.97B
Volume
1.62M
52W High
$122.20
52W Low
$45.91
PE Ratio
-28.11
RYTM Fundamentals
Price
$87.38
Prev Close
$91.15
Open
$88.84
50D MA
$100.47
Beta
0.96
Avg. Volume
769,376.83
EPS (Annual)
-$3.11
P/B
42.23
Rev/Employee
$458,350.24
$6,810.11
Loading...
Loading...
News
all
press releases
598,247 Shares in Rhythm Pharmaceuticals, Inc. $RYTM Purchased by Capital Research Global Investors
Capital Research Global Investors acquired a new position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) in the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Rhythm Pharmaceuticals (NASDAQ:RYTM) CAO Sells 5,614 Shares
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) CAO Christopher Paul German sold 5,614 shares of the stock in a transaction on Wednesday, March 4th. The stock was sold at an average...
MarketBeat·8d ago
News Placeholder
Rhythm Pharmaceuticals (NASDAQ:RYTM) CAO Sells $502,789.84 in Stock
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Get Free Report) CAO Christopher Paul German sold 5,614 shares of the company's stock in a transaction dated Wednesday, March 4th. The shares were sold at...
MarketBeat·9d ago
News Placeholder
Analysts Offer Predictions for RYTM FY2027 Earnings
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) - Equities research analysts at HC Wainwright issued their FY2027 earnings per share estimates for shares of Rhythm Pharmaceuticals in a...
MarketBeat·12d ago
News Placeholder
Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target Lowered to $140.00 at Canaccord Genuity Group
Canaccord Genuity Group decreased their target price on Rhythm Pharmaceuticals from $141.00 to $140.00 and set a "buy" rating on the stock in a report on Monday...
MarketBeat·13d ago
News Placeholder
HC Wainwright Cuts Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $110.00
HC Wainwright lowered their price target on shares of Rhythm Pharmaceuticals from $125.00 to $110.00 and set a "buy" rating on the stock in a report on Monday...
MarketBeat·13d ago
News Placeholder
Artisan Partners Limited Partnership Buys 62,362 Shares of Rhythm Pharmaceuticals, Inc. $RYTM
Artisan Partners Limited Partnership increased its stake in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM - Free Report) by 35.7% in the third quarter, according to the company in its most recent Form...
MarketBeat·14d ago
News Placeholder
Wells Fargo & Company Cuts Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $136.00
Wells Fargo & Company cut their price target on Rhythm Pharmaceuticals from $145.00 to $136.00 and set an "overweight" rating on the stock in a report on Friday...
MarketBeat·16d ago
News Placeholder
Citizens Jmp Raises Rhythm Pharmaceuticals (NASDAQ:RYTM) Price Target to $176.00
Citizens Jmp increased their target price on Rhythm Pharmaceuticals from $167.00 to $176.00 and gave the company a "market outperform" rating in a research note on Friday...
MarketBeat·16d ago
News Placeholder
Rhythm Pharmaceuticals Analysts Raise Their Forecasts After Upbeat Q4 Results
read more...
Benzinga·16d ago
<
1
2
...
>

Latest RYTM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.